Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis.

Angiogenesis is a critical process for tumor growth and metastatic dissemination. There is tremendous interest in the development of noninvasive methods for imaging tumor angiogenesis, and ultrasound (US) is an emerging platform technology to address this challenge. The introduction of intravascular microbubble contrast agents not only allows real-time visualization of tumor perfusion during an US examination, but they can be functionalized with specific ligands to permit molecular US imaging of angiogenic biomarkers that are overexpressed on the tumor endothelium. In this article, we will review current concepts and developing trends for US imaging of tumor angiogenesis, including relevant preclinical and clinicsal findings.

[1]  Sanjiv S Gambhir,et al.  US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. , 2008, Radiology.

[2]  Y. Imai,et al.  Quantification in Molecular Ultrasound Imaging , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[3]  B. Goldberg,et al.  Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity. , 2008, Ultrasound in medicine & biology.

[4]  Sanjiv S Gambhir,et al.  Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. , 2008, Radiology.

[5]  P. Barbosa,et al.  Focused abdominal ultrasound in preoperative liver surgery staging: a prospective study , 2013, World Journal of Surgical Oncology.

[6]  D. Merton,et al.  Parametric Imaging Using Subharmonic Signals From Ultrasound Contrast Agents in Patients With Breast Lesions , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[7]  S. Feinstein,et al.  Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation. , 1987, American heart journal.

[8]  Rakesh K. Jain,et al.  Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.

[9]  K. Chou,et al.  P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. , 2004, Current medicinal chemistry.

[10]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[11]  K W Ferrara,et al.  Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. , 2000, Academic radiology.

[12]  Vassilis Sboros,et al.  Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents , 2010, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[13]  L. Patterson,et al.  Function and antagonism of beta3 integrins in the development of cancer therapy. , 2009, Current cancer drug targets.

[14]  M. Mischi,et al.  Contrast-ultrasound dispersion imaging for prostate cancer localization by improved spatiotemporal similarity analysis. , 2013, Ultrasound in medicine & biology.

[15]  S. Fox,et al.  TUMOUR ANGIOGENESIS , 1996, The Journal of pathology.

[16]  K. Ley,et al.  scVEGF Microbubble Ultrasound Contrast Agents: A Novel Probe for Ultrasound Molecular Imaging of Tumor Angiogenesis , 2010, Investigative radiology.

[17]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[18]  C. Trautwein,et al.  Response evaluation of chemotherapy in metastatic colorectal cancer by contrast enhanced ultrasound. , 2012, World journal of gastroenterology.

[19]  Kumar Sharma,et al.  Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent , 2011, Investigative radiology.

[20]  R. Jain.  Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  François Tranquart,et al.  Ultrasound Molecular Imaging of VEGFR2 in a Rat Prostate Tumor Model Using BR55 , 2010, Investigative radiology.

[22]  Wolfhard Semmler,et al.  Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects , 2008, Molecular Cancer Therapeutics.

[23]  Lidian Chen,et al.  Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions. , 2010, European journal of radiology.

[24]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[25]  S. Bonvalot,et al.  [Treatment of local recurrent melanomas by isolated limb perfusion: value of Doppler ultrasonography]. , 2003, Journal de radiologie.

[26]  Jonathan R. Lindner,et al.  Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to &agr;v-Integrins , 2003, Circulation.

[27]  A. Fleischer.  Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[28]  B. Scheithauer,et al.  Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. , 2011, Anticancer research.

[29]  L. Du,et al.  Regions of interest and parameters for the quantitative analysis of contrast-enhanced ultrasound to evaluate the anti-angiogenic effects of bevacizumab. , 2013, Molecular medicine reports.

[30]  Rolf A. Brekken,et al.  Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature , 2007, Clinical Cancer Research.

[31]  Michael Scholz,et al.  Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions. , 2009, Neoplasia.

[32]  C. Sehgal,et al.  Delta-projection imaging on contrast-enhanced ultrasound to quantify tumor microvasculature and perfusion. , 2009, Academic radiology.

[33]  R. Brekken,et al.  VEGF-VEGF receptor complexes as markers of tumor vascular endothelium. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[34]  D. McDonald,et al.  Cellular abnormalities of blood vessels as targets in cancer. , 2005, Current opinion in genetics & development.

[35]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[36]  John A Hossack,et al.  Real-Time Technique for Improving Molecular Imaging and Guiding Drug Delivery in Large Blood Vessels: In Vitro and Ex Vivo Results , 2011, Molecular imaging.

[37]  Linda Chami,et al.  Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment , 2007, European radiology.

[38]  Molly L Flexman,et al.  Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. , 2012, Ultrasound in medicine & biology.

[39]  E. Rosenthal,et al.  Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy , 2013, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[40]  F. Forsberg,et al.  Contrast-enhanced ultrasound for molecular imaging of angiogenesis , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  C. Dietrich,et al.  An EFSUMB Introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for Quantification of Tumour Perfusion , 2012, Ultraschall in der Medizin.

[42]  S. Koscielny,et al.  Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography , 2010, Clinical Cancer Research.

[43]  Linda Chami,et al.  Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. , 2006, AJR. American journal of roentgenology.

[44]  Alexander L. Klibanov,et al.  Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging , 2009, Medical & Biological Engineering & Computing.

[45]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[46]  Xiaoping Zhou,et al.  A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[47]  Assessment of a new mathematical model for the computation of numerical parameters related to renal cortical blood flow and fractional blood volume by contrast-enhanced ultrasound. , 2009, Ultrasound in medicine & biology.

[48]  F. Foster,et al.  A method for differentiating targeted microbubbles in real time using subharmonic micro-ultrasound and interframe filtering. , 2009, Ultrasound in medicine & biology.

[49]  B. Goldberg,et al.  Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: initial results. , 2000, Ultrasonics.

[50]  Nathalie Lassau,et al.  Standardization of Dynamic Contrast-Enhanced Ultrasound for the Evaluation of Antiangiogenic Therapies: The French Multicenter Support for Innovative and Expensive Techniques Study , 2012, Investigative radiology.

[51]  Michel Claudon,et al.  Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts , 2001, European Radiology.

[52]  Yin Zhang,et al.  Multimodality molecular imaging of CD105 (Endoglin) expression. , 2011, International journal of clinical and experimental medicine.

[53]  P. Dayton,et al.  Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction , 2005, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[54]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[55]  A. Roche,et al.  [Evaluation of early response to antiangiogenic treatment with dynamic contrast enhanced ultrasound]. , 2008, Journal de radiologie.

[56]  Junru Wu,et al.  Bioeffects Considerations for Diagnostic Ultrasound Contrast Agents , 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[57]  Hendrikus H. M. Korsten,et al.  Maximum-Likelihood Estimation for Indicator Dilution Analysis , 2014, IEEE Transactions on Biomedical Engineering.

[58]  Fabian Kiessling,et al.  Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment. , 2013, Radiology.

[59]  Kenneth Hoyt,et al.  Molecular Ultrasound Imaging Using a Targeted Contrast Agent for Assessing Early Tumor Response to Antiangiogenic Therapy , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[60]  John C Gore,et al.  Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression Using Targeted Contrast‐Enhanced High‐Frequency Ultrasonography , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[61]  A. Harris,et al.  Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  S. Benson,et al.  Ultrasound is now better than mammography for the detection of invasive breast cancer. , 2004, American journal of surgery.

[63]  G. Benea,et al.  Effect of Angiosonography to Monitor Response During Imatinib Treatment in Patients with Metastatic Gastrointestinal Stromal Tumors , 2005, Clinical Cancer Research.

[64]  Paul A Dayton,et al.  Assessment of Molecular Imaging of Angiogenesis with Three-Dimensional Ultrasonography , 2011, Molecular imaging.

[65]  Ji-Bin Liu,et al.  Perfusion Estimation Using Contrast-Enhanced 3-dimensional Subharmonic Ultrasound Imaging: An In Vivo Study , 2013, Investigative radiology.

[66]  Paul A Dayton,et al.  Mapping microvasculature with acoustic angiography yields quantifiable differences between healthy and tumor-bearing tissue volumes in a rodent model. , 2012, Radiology.

[67]  R. Melton,et al.  Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody. , 1996, British Journal of Cancer.

[68]  Y. Imai,et al.  Arterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: a pilot study. , 2011, World journal of gastroenterology.

[69]  Wolfhard Semmler,et al.  Quantitative Contrast-Enhanced Ultrasound for Imaging Antiangiogenic Treatment Response in Experimental Osteolytic Breast Cancer Bone Metastases , 2012, Investigative radiology.

[70]  Kenneth Hoyt,et al.  Volumetric Contrast‐Enhanced Ultrasound Imaging to Assess Early Response to Apoptosis‐Inducing Anti–Death Receptor 5 Antibody Therapy in a Breast Cancer Animal Model , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[71]  A. Roche,et al.  valuation prcoce des traitements anti-angiogniques par chographie dynamique de contraste , 2008 .

[72]  Isabelle Tardy,et al.  BR55: A Lipopeptide-Based VEGFR2-Targeted Ultrasound Contrast Agent for Molecular Imaging of Angiogenesis , 2010, Investigative radiology.

[73]  Olivier Lucidarme,et al.  Angiogenesis model for ultrasound contrast research: exploratory study. , 2004, Academic radiology.

[74]  K. Hoyt,et al.  Quantitative Mapping of Tumor Vascularity Using Volumetric Contrast-Enhanced Ultrasound , 2011, Investigative radiology.

[75]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[76]  E. Rosenthal,et al.  Microbubble Therapy Enhances Anti-tumor Properties of Cisplatin and Cetuximab In Vitro and In Vivo , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[77]  K. Hoyt,et al.  Real-time volumetric contrast-enhanced ultrasound and microbubble destruction-replenishment imaging: Preliminary in vitro and in vivo results , 2012, 2012 IEEE International Ultrasonics Symposium.

[78]  E. Rosenthal,et al.  Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma. , 2012, Archives of otolaryngology--head & neck surgery.

[79]  R. Karshafian,et al.  Quantification of flow using ultrasound and microbubbles: a disruption replenishment model based on physical principles. , 2009, Ultrasound in medicine & biology.

[80]  Hairong Zheng,et al.  A sensitive TLRH targeted imaging technique for ultrasonic molecular imaging , 2010, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[81]  J. Willmann,et al.  Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging. , 2011, Radiology.

[82]  F. Kiessling,et al.  The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55) , 2013, European Radiology.

[83]  John A Hossack,et al.  Dual frequency method for simultaneous translation and real-time imaging of ultrasound contrast agents within large blood vessels. , 2009, Ultrasound in medicine & biology.

[84]  M. Brawer,et al.  Quantitative morphometric analysis of the microcirculation in prostate carcinoma , 1992, Journal of cellular biochemistry. Supplement.

[85]  Sanjiv S Gambhir,et al.  Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). , 2010, Radiology.

[86]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[87]  R. Jain,et al.  Oncotic pressure in solid tumors is elevated. , 2000, Cancer research.

[88]  Linda Chami,et al.  Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results. , 2011, Radiology.

[89]  M. Falconi,et al.  Contrast-Enhanced Ultrasonography Better Identifies Pancreatic Tumor Vascularization than Helical CT , 2005, Pancreatology.

[90]  F. Kiessling,et al.  Ultrasound Molecular Imaging of E-Selectin in Tumor Vessels Using Poly n-Butyl Cyanoacrylate Microbubbles Covalently Coupled to a Short Targeting Peptide , 2013, Investigative radiology.

[91]  Paul A Dayton,et al.  Quantitative Volumetric Perfusion Mapping of the Microvasculature Using Contrast Ultrasound , 2010, Investigative radiology.

[92]  Fabian Kiessling,et al.  Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38) , 2011, European Radiology.

[93]  Kenneth Hoyt,et al.  Determination of Breast Cancer Response to Bevacizumab Therapy Using Contrast‐Enhanced Ultrasound and Artificial Neural Networks , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[94]  Jiri Sklenar,et al.  Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. , 2003, Circulation.

[95]  Suhyun Park,et al.  Three-dimensional subharmonic ultrasound imaging in vitro and in vivo. , 2012, Academic radiology.

[96]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[97]  Kenneth Hoyt,et al.  A Triple‐Targeted Ultrasound Contrast Agent Provides Improved Localization to Tumor Vasculature , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[98]  M. Arditi,et al.  Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent. , 2012, Ultrasound in medicine & biology.

[99]  K W Ferrara,et al.  Selective imaging of adherent targeted ultrasound contrast agents , 2007, Physics in medicine and biology.

[100]  Andrej Lyshchik,et al.  Correlation of Quantified Contrast‐Enhanced Sonography With In Vivo Tumor Response , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[101]  B. Goldberg,et al.  Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study. , 2011, Ultrasonics.

[102]  Sanjiv S Gambhir,et al.  Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. , 2008, Radiology.

[103]  K. Hoyt,et al.  An animal model allowing controlled receptor expression for molecular ultrasound imaging. , 2013, Ultrasound in medicine & biology.

[104]  Caigang Liu,et al.  Contrast-enhanced ultrasonography of the rabbit VX2 tumor model: Analysis of vascular pathology. , 2012, Oncology letters.

[105]  S. Griffey,et al.  Contrast-Enhanced Computed Tomography and Ultrasound for the Evaluation of Tumor Blood Flow , 2005, Investigative radiology.

[106]  K. Hoyt,et al.  Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer , 2012, Journal of drug targeting.

[107]  Olivier Lucidarme,et al.  Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model. , 2006, Radiology.

[108]  K. Hoyt,et al.  Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents. , 2011, Ultrasound in medicine & biology.

[109]  Sunil Unnikrishnan,et al.  Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. , 2012, AJR. American journal of roentgenology.

[110]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.